Enteral Feeding Formula Market: By Type 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Enteral Feeding Formula Market
Enteral Feeding Formula Market: By Type (Standard Formula, Specialty Formula, Blenderized Formula); By Category (Adult & Children); By Form (Liquid & Powder); By End User (Hospitals, Clinics) & By Geography – Forecast (2018-2024)
Report Code : HCR 0288
Updated Date: 04 May, 2018  
14

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Enteral Feeding Formula Market Overview
2. Executive Summary
3. Enteral Feeding Formula Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Enteral Feeding Formula Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Enteral Feeding Formula Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Enteral Feeding Formula Market - By Type
   6.1. Introduction
   6.2. Standard Formula
   6.3. Specialty Formula
      6.3.1. Renal support
      6.3.2. Diabetes
      6.3.3. Hepatitis
      6.3.4. Pulmonary
      6.3.5. Others
   6.4. Blenderized Formula
      6.4.1. Meat
      6.4.2. Vegetables
      6.4.3. Fruits
      6.4.4. Others 
   6.5. Elemental Formula
   6.6. Semi-Elemental Formula
   6.7. Polymeric Formula
   6.8. Others
7. Enteral Feeding Formula Market - By Age Category
   7.1. Introduction
   7.2. Adult
   7.3. Children
8. Enteral Feeding Formula Market - By Routes of Delivery
   8.1. Introduction
   8.2. Oral
   8.3. Gastric
      8.3.1. Nasogastric
      8.3.2. Oro-gastric
      8.3.3. Gastrostomy
   8.4. Trans-pyloric
      8.4.1. Naso-jejunal
      8.4.2. Gastro-jejunostomy
      8.4.3. Jejunostomy
9. Enteral Feeding Formula Market - By Flavor Type
   9.1. Introduction
   9.2. Flavored
      9.2.1. Vanilla
      9.2.2. Strawberry 
      9.2.3. Others
   9.3. Non-Flavored
10. Enteral Feeding Formula Market - By Form
   10.1. Introduction
   10.2. Powder
   10.3. Liquid
11. Enteral Feeding Formula Market - By Application
   11.1. Introduction
   11.2. Gastrointestinal Disease
   11.3. Neurological Impairment 
   11.4. Pulmonary Disease
   11.5. Congenital Heart Disease
   11.6. Diabetes
   11.7. Kidney Failure
   11.8. Liver Disorders
   11.9. Cystic Fibrosis
   11.10. Malabsorption
   11.11. Short Bowel Syndrome
   11.12. Inflammatory bowel disease
   11.13. Others
12. Enteral Feeding Formula Market - By End User
   12.1. Introduction
   12.2. Hospitals
   12.3. Clinics
   12.4. Nursing Homes
   12.5. Home Care & Hospice Agencies
   12.6. Others
13. Enteral Feeding Formula Market - By Geography
   13.1. North America
      13.1.1. U.S.
      13.1.2. Canada
      13.1.3. Mexico
      13.1.4. Others
   13.2. South America
      13.2.1. Brazil 
      13.2.2. Venezuela
      13.2.3. Argentina
      13.2.4. Ecuador
      13.2.5. Peru
      13.2.6. Colombia 
      13.2.7. Costa Rica
      13.2.8. Others
   13.3. Europe
      13.3.1. Germany
      13.3.2. France
      13.3.3. U.K.
      13.3.4. Italy
      13.3.5. Spain
      13.3.6. Netherlands
      13.3.7. Belgium
      13.3.8. Others
   13.4. APAC
      13.4.1. China
      13.4.2. Japan
      13.4.3. South Korea
      13.4.4. Australia
      13.4.5. India
      13.4.6. Taiwan
      13.4.7. Malaysia
      13.4.8. Hong Kong
      13.4.9. Others
   13.5. RoW
      13.5.1. Middle East 
      13.5.2. Africa
      13.5.3. Russia 
      13.5.4. Others
14. Market Entropy
   14.1. New Product Launches
   14.2. M&As, Collaborations, JVs, Partnership
15. Company Profiles
   15.1. Abbott Laboratories (U.S.)
   15.2. Danone (France)
   15.3.  Nestle S.A. (Switzerland)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
16. Appendix
   16.1. Abbreviations
   16.2. Sources
   16.3. Research Methodology
   16.4. Bibliography
   16.5. Compilation of Expert Insights
   16.6. Disclaimer
The global Enteral Feeding Formula Market is estimated to surpass $14 billion by 2024 growing at an estimated rate of more than 9% during 2018 to 2024 majorly driven growing prevalence of chronic diseases and severe trauma cases across the globe. This is followed by the growing number of premature births and escalating geriatric population in developed economies

What is Enteral Feeding Formula?
Enteral feeding formulas are dietary preparations with equivalent nutritive value of food which are fed directly into the stomach, jejunum or duodenum through tubes. These formulas are preferred for patients experiencing difficulty in or are unable to swallow food orally. These formulas are cost effective supplements providing complete and balanced nutritive requirement of proteins, fibers, and other macro nutrients to the patients under various medical conditions thereby enhancing recovery.

Enteral feeding formulas with prebiotics are being developed for standard infant nutrition. These tube feeding formulas are targeting to strengthen the immune systems and treat or prevent inflammatory disorders. Standard enteral feeding formulas are analyzed to hold the prominent share of the market owing to its wide use for infants and premature cases. Further the growing awareness programs being initiated for tube feeling of growing children with various medical conditions by various government and non- government organizations is also set to assist the market growth in the upcoming years.

This report incorporates an in-depth assessment of enteral feeding formula market by type, age category, routes of delivery, flavor type, form, application, end user and geography. The major types of tube feeding formulas encompassed in the report scope includes standard formula, specialty formula, blender formula, elemental formula, semi-elemental formula, polymeric formula and so on.

What are the Applications for Enteral Feeding Formula?
The various end users assessed includes hospitals, clinics, nursing homes, homecare & hospice agencies and so on. As per recent estimates around 51,450 people are estimated to be diagnosed with oral cancer by the end of 2018 with escalating cases for oropharyngeal cancer both among men and women. The death rates from oral cancer has reduced significantly due to advanced treatment methods, alternative nutritional ingestion techniques such as tube feeding and early diagnosis of the malignant tumors. Further, the growing emphasis towards health for various children with medical disorders oriented to regular feeding habits is driving the demand for enteral feeding formulas into homecare and hospice agencies. This is also set to be assisted by the growing number of chronic cases in adults and older population. 

Enteral Feeding Formula Market

Market Research and Market Trends of Enteral Feeding Formula Ecosystem
  • KateFarms, a California based company offering vegan foods and drinks recently launched its Core Essentials Peptide 1.5 which is free from dairy, soy, gluten and other common allergens. This oral and tube feeding formula contains natural and easily digestible ingredients to provide necessary caloric density to promote healing of the gastrointestinal tract. The product is estimated to gain prominent adoption in the U.S. especially for patients with various allergic conditions
  • As per recent studies and clinical trials, children affected with mitochondrial diseases displaying nutritional deficiencies have shown positive results such as improved gastrointestinal symptoms on receiving tube feeding. This is estimated to pave the way for children enteral feeding formulas market for such medical conditions in the future
  • Alcresta Therapeutics, Inc., a U.S based expert in enzyme based products targeted to gastrointestinal disorders and rare diseases, recently received FDA approval for Relizorb, for use in children enteral feeding formulas. This an enzyme containing cartridge synthesizes fats in tube feeding formulas which proves to be very beneficial to for younger patients suffering from cystic fibrosis. The company also raised $49.9m in series C funding to support the launch of Relizorb in 2016. 
  • Nutrinia, Ltd., an Israel based company focused on development of proprietary insulin based oral formulations for intestinal malabsorption in premature infants and Short Bowel Syndrone (SBS) in infants; raised $30m series D funding in 2016, to fund its two pivotal trials for registrations. 

Who are the Major Players?
The companies referred to in the report includes Abbott Laboratories (U.S.), Danone (France), Nestle S.A. (Switzerland) and other prominent players. The report incorporates indepth assessment of the competitive landscape, SWOT analysis, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024
LIST OF TABLES:

Table 1: Global Enteral Feeding Formula Market Value, By Geography, 2015-2022 ($Billion) 
Table 2: Americas Enteral Feeding Formulas Market Value, By Country, 2015-2022 ($Billion) 
Table 3: Americas Enteral Feeding Formulas Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 4: Americas Enteral Feeding Formulas Market Value, By Product Type, 2015-2022 ($Billion)
Table 5: Europe Enteral Feeding Formulas Market Value, By Country, 2015-2022 ($Billion) 
Table 6: Europe Enteral Feeding Formulas Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 7: Europe Enteral Feeding Formulas Market Value, By Product Type, 2015-2022 ($Billion)
Table 8: Asia-Pacific: Enteral Feeding Formula Market Value, By Country, 2015-2022 ($Billion) 
Table 9: Asia-Pacific: Enteral Feeding Formula Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 10: Asia-Pacific: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion)
Table 11: RoW: Enteral Feeding Formula Market Value, By Country, 2015-2022 ($Billion) 
Table 12: RoW: Enteral Feeding Formula Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 13: RoW: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion)


LIST OF FIGURES:

Figure 1: Global Enteral Feeding Formula Market Value ($Billion) & Volume (KT), 2015-2022 
Figure 2: Global Enteral Feeding Formula Market Revenue, By Geography, 2015-2022 ($Billion) 
Figure 3: Global Enteral Feeding Formula Market Value Share, By Product Type, 2015 (%)
Figure 4: Global Enteral Feeding Formula Market Value Share, By Therapeutic Area, 2015 (%)
Figure 5: Global Enteral Feeding Formula Market Value, By Geography, 20,152,021 ($Million) 
Figure 6: Global Enteral Nutrition Market Share, 2016 (%) 
Figure 7: Global Clinical Nutrition Market Share, 2016 (%) 
Figure 8: Enteral Feeding Formula Patents, 2012-2016* 
Figure 9: Enteral Feeding Formula Market Share, By Therapeutic area, 2015 (%) 
Figure 10: EPS Representation: By Company, 2013-2015 ($) 
Figure 11: Bargaining Power of Suppliers – Enteral Feeding Formula Market 
Figure 12: Bargaining Power of Buyers – Enteral Feeding Formula Industry 
Figure 13: Threat from Substitutes – Enteral Feeding Formula Industry 
Figure 14: Threat from New Entrants – Enteral Feeding Formula Industry 
Figure 15: Enteral Feeding Formula Industry – Attractiveness 
Figure 16: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion) 
Figure 17: Standard Formula: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 18: Disease Specific Formula: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 19: Global Enteral Feeding Formula Market Revenue, By Therapeutic Area, 2015-2022 ($Billion) 
Figure 20: Oncology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 21: United States: Digestive Disease Statistics, By Hospitalizations, By Mortality, 2010 
Figure 22: Gastroenterology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 23: Neurology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 24: Critical Care: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 25: Others: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 26: U.S.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 27: U.S.: GDP – Composition of 2015, By Sector of Origin 
Figure 28: U.S.: Export and Import Value, 2012-2015 ($Trillion) 
Figure 29: U.S.: GDP – Composition of 2015, By End Use 
Figure 30: U.S.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 31: Canada: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 32: Canada: GDP – Composition of 2015, By Sector of Origin 
Figure 33: Canada: Export and Import Value, 2012-2015 ($Billion) 
Figure 34: Canada: GDP – Composition of 2015, By End Use 
Figure 35: Canada: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 36: Total Number of ICU Admission in Canada 
Figure 37: Mexico: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 38: Mexico: GDP – Composition of 2015, By Sector of Origin 
Figure 39: Mexico: Export and Import Value, 2012-2015 ($Billion) 
Figure 40: Mexico: GDP – Composition of 2015, By End Use 
Figure 41: Mexico: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 42: Brazil: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 43: Brazil: GDP – Composition of 2015, By Sector of Origin 
Figure 44: Brazil: Export and Import Value, 2012-2015 ($Billion) 
Figure 45: Brazil: GDP – Composition of 2015, By End Use 
Figure 46: Brazil: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 47: Rest of Americas: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 48: U.K.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 49: U.K.: GDP – Composition of 2015, By Sector of Origin 
Figure 50: U.K.: Export and Import Value, 2012-2015 ($Billion) 
Figure 51: U.K.: GDP – Composition of 2015, By End Use 
Figure 52: U.K.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 53: Germany: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 54: Germany: GDP – Composition of 2015, By Sector of Origin 
Figure 55: Germany: Export and Import Value, 2012-2015 ($Billion) 
Figure 56: Germany: GDP – Composition of 2015, By End Use 
Figure 57: Germany: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 58: Spain: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 59: Spain: GDP – Composition of 2015, By Sector of Origin 
Figure 60: Spain: Export and Import Value, 2012-2015 ($Billion) 
Figure 61: Spain: GDP – Composition of 2015, By End Use 
Figure 62: Spain.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 63: Spain: Population ages 65 and above (% of total) 
Figure 64: France: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 65: France: GDP – Composition of 2015, By Sector of Origin 
Figure 66: France: Export and Import Value, 2012-2015 ($Billion) 
Figure 67: France: GDP – Composition of 2015, By End Use 
Figure 68: France: Enteral Feeding Formulas Market,2015-2022 ($Billion) 
Figure 69: France: Population ages 65 and above (% of total) 
Figure 70: Total Percentage of the Elderly Population, By Country, 2015 
Figure 71: Rest of Europe: Enteral Feeding Formulas Market,2015-2022 ($Billion) 
Figure 72: China: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 73: China: GDP – Composition of 2015, By Sector of Origin 
Figure 74: China: Export and Import Value, 2012-2015 ($Billion) 
Figure 75: China: GDP – Composition of 2015, By End Use 
Figure 76: Oral Cavity Cancer Incidence in China, 2010 
Figure 77: China: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 78: Japan: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 79: Japan: GDP – Composition of 2015, By Sector of Origin 
Figure 80: Japan: Export and Import Value, 2012-2015 ($Billion) 
Figure 81: Japan: GDP – Composition of 2015, By End Use 
Figure 82: Number of Cancer Incidence by Age and Site(2011) 
Figure 83: Japan: Population ages 65 and above (% of total) 
Figure 84: Japan: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 85: India: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 86: India: GDP – Composition of 2015, By Sector of Origin 
Figure 87: India: Export and Import Value, 2012-2015 ($Billion) 
Figure 88: India: GDP – Composition of 2015, By End Use 
Figure 89: India: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 90: Trends in cancer incidence rates from 1999 to 2012 in Korea 
Figure 91: Rest of APAC: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 92: Middle East: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 93: Africa: Enteral Feeding Formula Market Value,2015-2022 ($Billion) 
Figure 94: Enteral Feeding Formula Market Entropy Share, By Strategies, 2012-2016* (%) 
Figure 95: Enteral Feeding Formula Market Entropy, By Total Number of Developments, 2012-2016* 
Figure 96: Nestle S.A.: Sales, by years 2013 – 2015 ($Billion) 
Figure 97: Nestle S.A.: Sales, by Operating segments, 2015 (%) 
Figure 98: Nestle S.A.: Sales, by Geography, 2015 (%) 
Figure 99: Merck & Co., Inc. , Net sales, By Years, 2013-2015 ($Billion) 
Figure 100: Merck & Co., Inc., Revenue Share,By Business Segment, 2015(%) 
Figure 101: Merck & Co., Inc., Revenue Share,By Geography, 2015(%) 
Figure 102: Meiji Holdings Co., Ltd., Net Sales, 2012-2016 ($B) 
Figure 103: Meiji Holdings Co., Ltd., Net Sales, By Business Segment, 2016 (%) 
Figure 104: B.Braun Melsungen AG Revenue, 2013-2015 ($Billion) 
Figure 105: B.Braun Melsungen AG Revenue Share, By Business Segment, 2015 (%) 
Figure 106: B.Braun Melsungen AG Revenue Share, By Geography, 2015 (%) 
Figure 107: Abbott Laboratories, Revenue, 2013-2015 ($Billion) 
Figure 108: Abbott Laboratories, Revenue, By Business Segment, 2015 (%) 
Figure 109: Abbott Laboratories, Revenue, By Region, 2015 (%) 
Figure 110: Baxter International Inc. , Net sales, By Years, 2013-2015 ($Billion) 
Figure 111: Baxter International Inc., Revenue Share, By Business Segment, 2015(%) 
Figure 112: Baxter International Inc., Revenue Share, By Geography, 2015(%) 
Figure 113: Danone, Revenue, 2013-2015 ($Million) 
Figure 114: Danone, Revenue, By Business Segment, 2015 (%) 
Figure 115: Danone, Revenue, By Region, 2015 (%) 
Figure 116: Fresenius Kabi AG Sales, 2013-2015 ($Billion) 
Figure 117: Fresenius Kabi AG Sales, By Business segments, 2015 (%) 
Figure 118: Fresenius Kabi AG Revenue Share, By Geography, 2015 (%) 
Figure 119: Mead Johnson Nutrition Company Net Sales, 2012-2015 ($Billion) 
Figure 120: Mead Johnson Nutrition Company Net Sales Share, By Geography, 2015 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll